General Information Job Advert Title: Drug Substance Lead, Upstream Bioprocess Science, CBTL, Product Research & Development Location: Tsukuba,Ibaraki Division: Product Research & Development Employment Class: Permanent Description 【募集の背景 / Purpose & Scope】 Astellas Pharma’s Product Research & Development (PR&D) organization,
By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms
By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms
By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms
General Information Job Advert Title: Scientist, Downstream Bioprocess Science, CBTL, Product Research & Development Location: Tsukuba, Ibaraki Division: Product Research & Development Employment Class: Permanent Description 【募集の背景 / Purpose & Scope】 Downstream Bioprocess Science Lab (DSBP) in Chemical
General Information Job Advert Title: Scientist, Analytical Research 3, Analytical Research Labs, Product Research & Development Location: Tsukuba, Ibaraki Division: Product Research & Development Employment Class: Permanent Description 【募集の背景 / Purpose & Scope】 The Analytical Research Laboratories support
General Information Job Advert Title: Senior Scientist, Discovery Formulation Location: Tsukuba, Ibaraki Division: Oncology Research Employment Class: Permanent Description 【About Astellas】 Astellas is a global life sciences company committed to turning innovative science into VALUE for
General Information Job Advert Title: Manager/ Senior Researcher, DDS, Technology Scouting & Integration Labs. 主任研究員，DDS，技術統合研究所 Location: Tsukuba,Ibaraki or Yaizu, Shizuoka Division: Product Research & Development Employment Class: Permanent Description 【募集の背景 / Purpose & Scope】 DDS (drug delivery system)
Channel Account Manager, Matterport - Tokyo Job Description COSTAR GROUP - CHANNEL ACCOUNT MANAGER, MATTERPORT - TOKYO OVERVIEW CoStar Group is a leading global provider of commercial and residential real estate information, analytics, and online marketplaces.
Channel Account Manager, Matterport - Tokyo Job Description COSTAR GROUP - CHANNEL ACCOUNT MANAGER, MATTERPORT - TOKYO OVERVIEW CoStar Group is a leading global provider of commercial and residential real estate information, analytics, and online marketplaces.
General Information Job Advert Title: Senior Research Associate Location: Tsukuba,Ibaraki Division: Oncology Research Employment Class: Permanent Description 【About Astellas】 Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We
General Information Job Advert Title: Senior Scientist, Innate Immunity & Cancer Cell Death Biology Location: Tsukuba,Ibaraki Division: Oncology Research Employment Class: Permanent Description 【About Astellas】 Astellas is a global life sciences company committed to turning innovative
General Information Job Advert Title: Scientist I, Innate Immunity & Cancer Cell Death Biology Location: Tsukuba,Ibaraki Division: Oncology Research Employment Class: Permanent Description 【About Astellas】 Astellas is a global life sciences company committed to turning innovative
General Information Job Advert Title: Scientist I, Cancer Driver Biology Location: Tsukuba,Ibaraki Division: Oncology Research Employment Class: Permanent Description 【About Astellas】 Astellas is a global life sciences company committed to turning innovative science into VALUE for
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)